These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19033875)

  • 1. Efficacy of anakinra in a case of refractory Still disease.
    Debiais S; Maillot F; Luca L; Buret J; Fautrel B; Renard JP
    J Clin Rheumatol; 2008 Dec; 14(6):357-8. PubMed ID: 19033875
    [No Abstract]   [Full Text] [Related]  

  • 2. Subacute liver failure following anakinra treatment for adult-onset Still disease.
    Aly L; Iking-Konert C; Quaas A; Benten D
    J Rheumatol; 2013 Oct; 40(10):1775-7. PubMed ID: 24085761
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

  • 4. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
    Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
    Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.
    Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S
    Mod Rheumatol; 2014 Nov; 24(6):1030-1. PubMed ID: 24313885
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
    Guignard S; Dien G; Dougados M
    Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease.
    Woo P
    Ann Rheum Dis; 2008 Mar; 67(3):281-2. PubMed ID: 18292104
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
    Vordenbäumen S; Ostendorf B; Sander O; Richter J; Schneider M
    Ann Rheum Dis; 2009 Mar; 68(3):450-1. PubMed ID: 19213754
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.
    Ruiz PJ; Masliah E; Doherty TA; Quach A; Firestein GS
    Ann Rheum Dis; 2007 Mar; 66(3):422-3. PubMed ID: 17179171
    [No Abstract]   [Full Text] [Related]  

  • 10. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
    Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
    Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
    Kalliolias GD; Georgiou PE; Antonopoulos IA; Andonopoulos AP; Liossis SN
    Ann Rheum Dis; 2007 Jun; 66(6):842-3. PubMed ID: 17513574
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory adult onset Still's disease successfully treated with anakinra.
    Vasques Godinho FM; Parreira Santos MJ; Canas da Silva J
    Ann Rheum Dis; 2005 Apr; 64(4):647-8. PubMed ID: 15374853
    [No Abstract]   [Full Text] [Related]  

  • 14. A patient's wish: anakinra in pregnancy.
    Berger CT; Recher M; Steiner U; Hauser TM
    Ann Rheum Dis; 2009 Nov; 68(11):1794-5. PubMed ID: 19822718
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
    Nordström D; Knight A; Luukkainen R; van Vollenhoven R; Rantalaiho V; Kajalainen A; Brun JG; Proven A; Ljung L; Kautiainen H; Pettersson T
    J Rheumatol; 2012 Oct; 39(10):2008-11. PubMed ID: 22859346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
    Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
    Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes.
    Youssef J; Lazaro E; Blanco P; Viallard JF
    J Rheumatol; 2008 Dec; 35(12):2453-6. PubMed ID: 19143047
    [No Abstract]   [Full Text] [Related]  

  • 19. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
    Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
    Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.